
$4389 8x EV/EBIT
Paul
149 posts


$4389 8x EV/EBIT





Also heute, im Supermarkt, Frosta, unglaublich, Skandal!11!



Adding $8917 First Juken Co to Japanese Net Net basket. 58% of NCAV, 4.2% dividend, 6.09% 10Y ROE Avg, 4.38% Book Value CAGR growth in the past 5 years selling at 36% of book. Since going public 7 years ago, positive Net Income and OI every year. Biggest concerns are inventory buildup, declining revenue, 54% of NCAV in inventory, and management still no disclosure on TSE Exchange reforms AKA “Action to Implement Management That Is Conscious of Cost of Capital and Stock Price”









BREAKING: Anthropic's pre-IPO valuation surges to a record $1.2 trillion, rising another +20% in 7 days. This officially puts Anthropic's implied valuation up +900% since October 2025, per onchain pre-IPO trading data. Pre-IPO instruments trading onchain on Jupiter, backed 1:1 by SPV exposure, are providing a real-time proxy for the company’s implied IPO valuation. This now makes Anthropic ~20% larger than OpenAI's pre-IPO implied valuation. If Anthropic were to IPO at a $1.2 trillion valuation, it would be the 11th most valuable public company in the world. The AI Revolution is accelerating.

Ich werde am Mittwoch um 18 Uhr bei dem bekannten und beliebten Youtuber @benungeskriptet zu Gast sein. Schaltet ein!

Repligens Q1 är klart bullish för Life Science Tools. - 11% organisk tillväxt med comeback från emerging biotech som växte 20%. - biotech funding i Q1 var upp 100% y/y med väldigt stark fortsättning i april. - ser hälsosam efterfrågan inom cellterapi och även inom genterapi.


